Read More 1 minute read Funding News News Encellin Secures $9.9M in Funding to Advance Revolutionary EnCRT for Type 1 Diabetes Key Highlights $9.9M financing round led by Khosla Ventures, with Y Combinator’s participation. Encellin’s EnCRT aims to transform T1D treatment with… byChris-Anne RoqueDecember 15, 2023